Search

Your search keyword '"Bevot A"' showing total 392 results

Search Constraints

Start Over You searched for: Author "Bevot A" Remove constraint Author: "Bevot A"
392 results on '"Bevot A"'

Search Results

1. Next-generation phenotyping integrated in a national framework for patients with ultrarare disorders improves genetic diagnostics and yields new molecular findings

2. Efficacy and safety of gene therapy with onasemnogene abeparvovec in children with spinal muscular atrophy in the D-A-CH-region: a population-based observational studyResearch in context

6. RORA-neurodevelopmental disorder: A unique triad of developmental disability, cerebellar anomalies, and myoclonic seizures

8. Botulinum neurotoxin type A in the interdisciplinary treatment of sialorrhea in adults and children—update and practice recommendations

9. Genotype-phenotype correlations in RHOBTB2-associated neurodevelopmental disorders

13. Non-Invasive Quantitative Approximation of Intracranial Pressure in Pediatric Idiopathic Intracranial Hypertension Based on Point-of-Care Ultrasound of the Optic Nerve Sheath Diameter

15. Heterozygous truncating variants in SUFU cause congenital ocular motor apraxia

20. Botulinum neurotoxin type A in the interdisciplinary treatment of sialorrhea in adults and children—update and practice recommendations

28. Evaluating the safety of perioperative dexamethasone treatment: A retrospective analysis of a single center pediatric low‐grade glioma cohort

32. Long-Term Follow-Up of Pediatric Patients with Dyskinetic Cerebral Palsy and Deep Brain Stimulation

33. Genotype-phenotype correlations in RHOBTB2-associated neurodevelopmental disorders

35. A further case of AFG2B‐related neurodevelopmental disorder with hearing loss and microcephaly allows further clarification of pathogenicity of the variant c.1313T>C, p.(Leu438Pro).

36. Non-Invasive Quantitative Approximation of Intracranial Pressure in Pediatric Idiopathic Intracranial Hypertension Based on Point-of-Care Ultrasound of the Optic Nerve Sheath Diameter.

37. Genotype–phenotype correlation and treatment effects in young patients withGNAO1-associated disorders

38. Next-generation phenotyping integrated in a national framework for patients with ultra-rare disorders improves genetic diagnostics and yields new molecular findings

40. Behandlung der Sialorrhoe mit Botulinum Neurotoxin Typ A – Konsentierte Praxisempfehlungen für Kinder und Erwachsene

41. Next-generation phenotyping integrated in a national framework for patients with ultra-rare disorders improves genetic diagnostics and yields new molecular findings

42. Chronic Pleural Effusion in Ventriculoperitoneal Shunt due to Diaphragmatic CSF Fistula. Report of a case treated by Endoscopic Choroid Plexus Coagulation and literature review

44. Solving unsolved rare neurological diseases-a Solve-RD viewpoint

45. Epilepsy in Aicardi–Goutières syndrome

46. Genotype-phenotype correlation and treatment effects in young patients with GNAO1-associated disorders.

47. Improved upper limb function in non-ambulant children with SMA type 2 and 3 during nusinersen treatment: a prospective 3-years SMArtCARE registry study

48. ALG6-CDG: a recognizable phenotype with epilepsy, proximal muscle weakness, ataxia and behavioral and limb anomalies

50. LGG-51. Resection extent and BRAF V600E mutation status determine postoperative growth velocity in pediatric Low-grade glioma: Results from a single-center cohort analysis

Catalog

Books, media, physical & digital resources